Pharmacogenomics in Drug Development Pipelines explores the integration of genetic insights into the drug discovery and development process. It covers target identification, biomarker development, and personalized clinical trial designs based on genetic profiles. The book emphasizes enhancing drug efficacy and safety through pharmacogenomic strategies. Suitable for pharmaceutical scientists and drug developers, it advances the incorporation of genetics in new drug creation.
Alexander Gray specializes in integrating pharmacogenomics into drug development pipelines to create personalized dermatological therapies. His research focuses on how genetic insights can guide the design, testing, and optimization of new skin medications. Alexander has published extensively on incorporating pharmacogenomic data into each stage of the drug development process to enhance efficacy and safety. He also provides guidelines for pharmaceutical researchers to integrate pharmacogenomic strategies into drug development pipelines, promoting the creation of effective and personalized dermatological treatments through informed pharmacogenomic practices.